Top AI Companies in NYC, NY (1,094)

Strong Revenue Growth: Evidence points to rapid scaling of annualized revenue into the hundreds of millions, with clear acceleration over recent periods. Independent reporting describes substantial increases in run rate alongside rising platform usage and enterprise adoption.

Investor Backing & Capital Strength: A large late-stage funding round at a significantly higher valuation underscores strong investor confidence and ample access to capital. Coverage links this financing to momentum in customer growth and expansion initiatives.

Innovation-Driven Growth: AI-driven development and agent-triggered deployments are frequently identified as major catalysts for increased platform activity. The company’s push into AI infrastructure and tools appears to be opening new demand vectors beyond its original hosting focus.

Strong Revenue Growth: ARR increased from $100M in early 2024 to over $200M by January 2026, and placement on Deloitte’s Technology Fast 500 signals substantial multi‑year expansion. While full audited statements aren’t public, these recurring‑revenue milestones and independent rankings indicate material scale-up.

Innovation-Driven Growth: AI-powered accounting Agents introduced in 2025 are cited as driving enterprise adoption and expanding automation across recurring workflows. Product development beyond close management supports broader accounting operations use cases.

Market Expansion: International reach broadened with offices in London and Sydney and reported momentum across EMEA. A managed-services agreement with EY and a push into larger enterprises point to widening market access.

Strong Revenue Growth: Revenue momentum is reflected in ARR rising from $100 million to over $200 million within roughly six months after an under-18-month climb to the first $100 million.

Investor Backing & Capital Strength: Recent financing includes a $550 million Series E at an $8.8 billion valuation, a sharp step-up from earlier 2026 rounds. This signals ample resources to fund continued expansion.

Market Expansion: Operations span 80+ markets with the United States becoming the largest revenue market and more than half of AmLaw 50 firms as customers. Headcount surpassed 1,000 across 18 offices, supporting international scaling.

Resilient & Sustainable Growth: Recent disclosures indicate modest, continued revenue expansion, including mid‑single‑digit year-over-year growth, supported by recurring demand in utilities, government, and insurance. This pattern points to steady momentum rather than rapid swings.

Strong Market Position & Advantage: The company serves 250+ enterprise clients and reaches over 40% of U.S. and Canadian households, signaling deep penetration in essential-service verticals. This embedded footprint provides a sizable base for incremental adoption and cross-sell.

Innovation-Driven Growth: Product launches such as the cloud-native KUBRA HQ platform and AI-driven IVR+ and IncidentWatch+ show ongoing investment across billing, payments, and communications. These additions broaden capabilities and can open new growth avenues.

Strong Revenue Growth: Recent results indicate sales are rising sharply, with fiscal Q3 2026 revenue increasing significantly year over year and management lifting its revenue outlook for both FY2026 and FY2027. Growth is broad-based across servers, networking, and the Cloud & AI segment, underscoring strong top-line momentum.

Profitability: Operating performance has strengthened materially, with operating profit up sharply and margins expanding in the latest quarter. Guidance points to continued non-GAAP earnings growth into FY2027, suggesting improved earnings durability.

Healthy Cash Flow: Cash generation is strengthening, with free cash flow rising to about $1.0B in the latest quarter. The outlook targets at least $5B of free cash flow in FY2027, signaling robust internal funding capacity.

Investor Backing & Capital Strength: Access to capital is described as strong, highlighted by approximately $1.6 billion in 2025 financing (a ~$500 million Series D plus a $1.1 billion term loan) at an estimated $5 billion valuation. This funding is positioned to support expansion beyond parking into areas such as airports, retail, fueling, hospitality, and drive‑throughs.

Strong Market Position & Advantage: Operating scale is portrayed as substantial after the SP Plus acquisition, creating 4,000+ locations and 20,000+ employees and later exceeding 4,200–4,500 locations. Combining this footprint with AI-driven, checkout‑free capabilities positions the company as a leading North American parking operator.

Market Expansion: Reach is widening with reported deployments at 100+ airports and moves into adjacent categories like fueling, drive‑throughs, hospitality, and retail. Reported growth to 21–30+ million members and continued location additions indicate an expanding addressable market.

Strong Revenue Growth: Revenue is described as rising at a strong, double‑digit pace across recent quarters and years, with subscription sales increasing alongside total revenue. Company guidance for subscription revenue was raised, reinforcing the momentum.

Resilient & Sustainable Growth: Remaining performance obligations and current contracted revenue expanded, indicating meaningful visibility into future sales. Growth in large enterprise customers and multi‑million‑dollar deals further supports durability.

Innovation-Driven Growth: AI offerings became a meaningful commercial driver as ServiceNow AI exceeded $1 billion in annual contract value and deployments accelerated. Adoption of workflow and AI products is highlighted as a primary catalyst.

Investor Backing & Capital Strength: Capital raising includes a $372 million Series D in 2024 with participation from Sanofi, bringing total funding above $600 million. The stated use of proceeds was to expand the drug pipeline and AI platform, indicating a strong financial base for growth.

Product Line Growth: The portfolio has expanded through multiple in-licensing deals in 2025–2026 and now spans preclinical, Phase 1, and Phase 2 programs. Tangible execution includes dosing the first participant in the BLKR201 Phase 1 trial in June 2026, only months after licensing the asset.

Strategic Partnerships: High-profile collaborations include work with Sanofi and OpenAI to build AI tools for drug development, alongside a Sanofi licensing agreement for gusacitinib with significant potential milestone value. These relationships reinforce external validation and create pathways to scale development.

Market Expansion: Available evidence indicates a deliberate shift from forestry toward electric-utility operations, with use cases now spanning vegetation management, asset inspection, construction, and storm response. Customer-facing materials also describe scaled deployments at major utilities and a larger New York headquarters lease consistent with expansion.

Product Line Growth: Product updates show next‑generation backpack and vehicle data‑collection hardware shipped to customers, expanded species‑identification models, faster data processing, and new planning and construction‑monitoring capabilities. These developments suggest the platform is broadening beyond data capture into decision‑support workflows.

Investor Backing & Capital Strength: The company reports an $11.35 million Series A led by Inspired Capital, with third‑party trackers indicating roughly $16–17 million raised in total. This funding base supports continued product and commercial scaling, even though it is not a proxy for revenue growth.

Investor Backing & Capital Strength: Canoe raised $36 million in a Series C led by Goldman Sachs Alternatives, with its valuation reported at more than 3× its 2023 Series B. Bloomberg completed its acquisition in October 2026 and indicated continued investment in the platform.

Market Expansion: The customer community exceeded 500 firms across more than two dozen countries, with more than 35 new firms in EMEA and six in APAC joining in 2025. Headcount additions and regional growth point to expanding international reach and market penetration.

Innovation-Driven Growth: The company launched Canoe AI and Canoe Labs and expanded its partner ecosystem, reporting over 600 connected portals in 2025. These developments broaden product capabilities and integration depth across private-markets workflows.

Strong Revenue Growth: Financial results indicate year-over-year revenue increased in 2025 and continued to rise at a faster pace in early 2026, with organic growth remaining in the high single digits. Consecutive quarterly reports through mid-2026 point to sustained top-line momentum.

Profitability: Operating income grew faster than revenue across recent periods, and adjusted measures showed sizable gains. These trends signal margin expansion and improving operating leverage.

Diversified Revenue Streams: Expansion is coming from multiple businesses—credit ratings, the Morningstar Direct Platform, retirement, and PitchBook—albeit at different growth rates. Segment disclosures highlight that growth is not concentrated in a single product line.

Investor Backing & Capital Strength: A $31 million Series B in February 2026, bringing reported total funding to about $46 million, indicates strong capital support and plans to scale. Public announcements and independent reporting corroborate the raise and its use for expansion.

Market Expansion: The company states it is moving beyond R&D tax credits into broader U.S. tax and accounting workflows, including areas like 179D deductions and cost segregation. Funding communications explicitly frame the new capital as fuel for this expansion.

Product Line Growth: Positioning now spans R&D credits, 179D deductions, cost segregation, amended returns, and corporate tax returns, signaling a broader offering than its original focus. Partnership activity and integrations further suggest a platform-scale product strategy.

Product Line Growth: Newer and acquired medicines grew 18% operationally in Q2 2026, while revenue excluding Comirnaty and Paxlovid rose 5% operationally in the same period. Excluding COVID products, 2025 revenue also increased 6% operationally, supported by growth in products such as Eliquis and Padcev.

Cost & Operational Efficiency: Management is pursuing additional savings to improve operational efficiency and support profitability. These cost-control efforts are intended to help the business transition away from pandemic-driven sales while supporting margins.

Innovation-Driven Growth: Investment in future growth includes $10.4 billion in internal R&D during 2025 and ongoing development in oncology and obesity. A broad pipeline and recent acquisitions are intended to offset declining COVID-19 sales and patent expirations if programs succeed.

Strong Revenue Growth: Reported subscription revenue nearly quadrupled from $8M to $29M while contracted revenue surpassed $60M. These figures indicate accelerating monetization tied to expanding deployments.

Investor Backing & Capital Strength: A $70M Series C in September 2026 brought total funding to $225M alongside a valuation above $500M. This level of committed capital suggests substantial capacity to scale sales, hardware, and AI development.

Market Expansion: Technology is deployed across 500+ senior-living communities and monitors roughly 40,000 residents, with stated plans to expand go-to-market efforts. Adoption across major senior-housing investors and operators points to a broadening commercial footprint.

Investor Backing & Capital Strength: External capital support is considered robust, with a $20 million Series A led by a strategic investor and an announced debt facility of up to $100 million to finance customer purchases. These resources position the company to scale originations and operations.

Strategic Partnerships: Partnerships with established technology vendors and infrastructure providers, including enterprise compute and GPU-focused programs, indicate expanding commercial channels. Customer stories with firms such as HPE, Lambda, and others suggest traction across software and AI infrastructure use cases.

Market Expansion: The offering has broadened from software financing into cloud, GPU/compute, hardware, and vendor-branded credit programs. Recent launches, including an AI-enabled agent and a refreshed platform, point to continued product and market development.

Investor Backing & Capital Strength: STG’s 2025 acquisition and the earlier $55 million Series D at roughly a $1.3 billion valuation indicate substantial financial support for the company’s next phase. This backing is framed as enabling continued development and scaling.

Market Expansion: Expansion of the Da Vinci AI platform across the UK and Europe, alongside global operations and more than 100 new enterprise wins in the year before mid-2025, points to widening geographic and commercial reach. International deployments and named brand traction support broader market presence.

Innovation-Driven Growth: Ongoing AI-focused product releases—such as Da Vinci enhancements and 2026 launches including Programmatic CRM and AI assistants—show sustained investment in new capabilities. These additions extend into mobile and cross-channel personalization, signaling an innovation-led growth approach.

Strong Revenue Growth: Revenue at the original email business is described as rising from roughly $30M ARR at the end of 2024 to about $35M by mid-2025, based on independent estimates. This points to solid momentum ahead of the acquisition.

Product Line Growth: The company broadened its suite beyond Mail to include Grammarly, Docs, and Go, and added meeting intelligence via the Fathom acquisition. This expansion indicates intentional widening of use cases and monetization paths.

Market Expansion: A new Seattle office with capacity for additional headcount and stated plans to keep hiring reflect continued geographic and workforce build-out. The organization also reports a large global team, underscoring operational scale.

Strong Revenue Growth: Revenue reportedly grew nearly sevenfold in 2025, indicating rapid commercial acceleration. Subsequent disclosures also describe expanding deployments across the U.S., Europe, and the Middle East.

Investor Backing & Capital Strength: A $22 million Series A announced on January 29, 2026 provided capital to scale the forward-deployed engineering model and AI application platform. An agreed acquisition by The OpenAI Deployment Company further signals strong strategic interest.

Strategic Partnerships: Designation as Palantir’s first and only Vanguard: Elite partner underscores a privileged ecosystem position tied to customer deployment success. The launch of a Google Cloud Gemini Enterprise practice points to broadening alliance activity.

Market Expansion: Feedback suggests the platform supports 385,000+ employees and families across 75+ companies, indicating growing reach and enterprise adoption.

Strong Hiring & Retention: Hiring activity and team scaling into a 51–200+ employee range are presented as signs of organizational growth capacity.

Investor Backing & Capital Strength: A $10 million seed round led by FUSE, with participation from other investors, is cited as providing runway for product and go-to-market scaling.

Investor Backing & Capital Strength: Investor support includes a Series A led by Emergence Capital with participation from Lux Capital and Susa Ventures to expand the platform and team. Funding activity signals access to growth capital despite limited public financial disclosures.

Market Expansion: Operating scope is widening from venture capital into private equity and private credit, alongside sharply higher reported assets under administration and a website claim of serving 10,000 limited partners. Case studies describing rapid onboarding of large mandates point to increasing customer adoption and operational scale.

Innovation-Driven Growth: An AI-native, vertically integrated platform combining fund administration, portfolio intelligence, and LP services is emphasized as a core differentiator. Customer stories highlight rapid closes and automation with expert review, suggesting product-led growth.